Table 3 Pre-hospital PCCD Use for All Pelvic Fractures at Level 1 Trauma Centers
Apply PCCD to All Pelvic Fractures n = 11 | Do not Apply PCCD to All Pelvic Fractures n = 14 | p | |
|---|---|---|---|
Guideline followed | |||
EAST | 38% (3) | 63% (5) | 0.89 |
WTA | 50% (2) | 50% (2) | |
TQIP | 0% (0) | 100% (2) | |
ATLS | 50% (1) | 50% (1) | |
MTP in Guideline? | |||
Yes | 55% (6) | 71% (10) | 0.43 |
No | 45% (5) | 29% (4) | |
Other Blood Products in Guideline? | |||
Yes | 45% (5) | 43% (6) | > 0.99 |
No | 55% (6) | 57% (8) | |
Region | |||
Midwest | 63% (3) | 38% (5) | 0.36 |
Northeast | 75% (3) | 25% (1) | |
South | 25% (2) | 75% (6) | |
West | 60% (3) | 40% (2) | |
Length in time as an ACS-Verified Level 1 Center | |||
< 1 year | 50% (1) | 50% (1) | 0.36 |
≥ 1 year to 2 years | 0 | 100% (3) | |
≥ 2 years to 5 years | 33% (2) | 67% (4) | |
≥ 5 years to 10 years | 100% (1) | 0 | |
≥ 10 years | 54% (7) | 46% (6) | |
Volume of Trauma Admissions in 2017 | |||
Low-volume | 100% (1) | 0 | > 0.99 |
High-volume | 46% (11) | 54% (13) | |